# Novan, Inc. clinical trials: 21 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Novan, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Novan, Inc.: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/novan-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 2, 2020 | NCT04535531 | A Phase 3 Molluscum Contagiosum Efficacy and Safety Study | Novan, Inc. | Phase 3 | Completed | Molluscum Contagiosum | 891 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04535531) |
| April 25, 2019 | NCT03927716 | A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1) | Novan, Inc. | Phase 3 | Completed | Molluscum Contagiosum | 352 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03927716) |
| April 25, 2019 | NCT03927703 | A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC | Novan, Inc. | Phase 3 | Completed | Molluscum Contagiosum | 355 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03927703) |
| February 26, 2018 | NCT03445013 | A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis | Novan, Inc. | Phase 1 | Completed | Psoriasis | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03445013) |
| February 19, 2018 | NCT03436615 | A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum | Novan, Inc. | Phase 2 | Completed | Molluscum Contagiosum | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03436615) |
| February 13, 2018 | NCT03431610 | A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis | Novan, Inc. | Phase 1 | Completed | Atopic Dermatitis | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03431610) |
| August 9, 2016 | NCT02860052 | SB208 for the Treatment of Tinea Pedis | Novan, Inc. | Phase 2 | Completed | Tinea Pedis | 222 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02860052) |
| June 16, 2016 | NCT02801903 | Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02801903) |
| June 14, 2016 | NCT02798120 | P3 Long Term Safety Study of Once Daily SB204 in Acne | Novan, Inc. | Phase 3 | Completed | Acne Vulgaris | 601 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02798120) |
| February 3, 2016 | NCT02672332 | P3 Study in Acne Comparing Once Daily SB204 and Vehicle | Novan, Inc. | Phase 3 | Completed | Acne Vulgaris | 1,307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02672332) |
| January 29, 2016 | NCT02667444 | P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne | Novan, Inc. | Phase 3 | Completed | Acne Vulgaris | 1,330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02667444) |
| October 20, 2015 | NCT02581072 | A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02581072) |
| June 3, 2015 | NCT02462187 | Topical NVN1000 for the Treatment of External Genital and Perianal Warts | Novan, Inc. | Phase 2 | Completed | Genital Warts, Perianal Warts | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02462187) |
| September 26, 2014 | NCT02250430 | A Phase 1 Study Assessing Local Cutaneous Effects of SB204 | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02250430) |
| September 17, 2014 | NCT02242760 | P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris | Novan, Inc. | Phase 2 | Completed | Acne Vulgaris | 213 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02242760) |
| June 16, 2014 | NCT02164084 | A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02164084) |
| May 1, 2013 | NCT01844752 | A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne | Novan, Inc. | Phase 2 | Completed | Acne Vulgaris | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01844752) |
| May 1, 2013 | NCT01844739 | A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01844739) |
| December 24, 2012 | NCT01755247 | A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01755247) |
| September 27, 2012 | NCT01694810 | Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers | Novan, Inc. | Phase 1 | Completed | Acne Vulgaris | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01694810) |
| March 16, 2012 | NCT01556698 | Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris | Novan, Inc. | Phase 1/2 | Completed | Acne Vulgaris, Acne | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01556698) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 9 |
| Phase 1/2 | 1 |
| Phase 2 | 5 |
| Phase 3 | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 21 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Acne Vulgaris | 13 |
| Molluscum Contagiosum | 4 |
| Condylomata Acuminata | 1 |
| Psoriasis | 1 |
| Dermatitis, Atopic | 1 |
| Tinea Pedis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Education services in the United States](https://specstream.ai/data/businesses/education-services/united-states)
- [Driving schools in the United States](https://specstream.ai/data/businesses/driving-schools/united-states)
- [Distilleries in the United States](https://specstream.ai/data/businesses/distilleries/united-states)
- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Credit unions in the United States](https://specstream.ai/data/businesses/credit-unions/united-states)
- [Cosmetic dentistry practices in the United States](https://specstream.ai/data/businesses/cosmetic-dentistry-practices/united-states)
